Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$16.5M
-33.3% from 2023
Prescriptions
568K
$29.08 per claim
Patients
142K
77,259 prescribers
Total spending, 2024
$16.5M
$116.31 per patient
Medicare prescription drug plans paid $16.5M for Bisoprolol-Hydrochlorothiazide in 2024, for 568,089 prescriptions and refills to 142,005 patients (down 33.3% from 2023). The average cost per claim was $29.08.
Texas had the highest Medicare cost for Bisoprolol-Hydrochlorothiazide in 2024: $1.2M for 42,191 claims, followed by New York ($1.0M).
Carlos J Carro Pagan, cardiology in Ponce, PR, had the highest Medicare cost for Bisoprolol-Hydrochlorothiazide in 2024: 989 claims costing $24K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Carlos J Carro Pagan Ponce, PR | Cardiology | 989 | 198 | $24K |
| Rabindra Girdhar Pittsburgh, PA | Cardiology | 574 | 178 | $20K |
| Edwin Alejandro |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 78,820 | 614,669 | 151,575 | $23.6M |
| 2023 | 77,567 | 581,655 | 145,346 | $24.8M |
| 2024 | 77,259 | 568,089 | 142,005 | $16.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 402 |
| 135 |
| $17K |
| Myron E Shirasu Honolulu, HI | Internal Medicine | 245 | 66 | $17K |
| Ali Nasser Lady Lake, FL | Cardiology | 711 | 229 | $17K |
| Luis Molinary Fernandez Bayamon, PR | Cardiology | 711 | 146 | $17K |
| Douglas Welsh Norfolk, NE | Interventional Cardiology | 373 | 119 | $14K |
| Daljit Singh Pittsburgh, PA | Internal Medicine | 377 | 94 | $13K |
| James G Sullivan Birmingham, AL | Internal Medicine | 482 | 140 | $13K |
| Ivan S Ayala San Juan, PR | Cardiology | 285 | 90 | $12K |
| Stanley W Smith Newnan, GA | Internal Medicine | 373 | 89 | $12K |
| James C Hall Union City, TN | Cardiology | 474 | 110 | $11K |
| Edward G Carlos Mobile, AL | Internal Medicine | 262 | 85 | $11K |
| Jeffrey D Sparks Burlington, NC | Internal Medicine | 292 | 74 | $10K |
| Hector J Colombany Lorenzo Aguadilla, PR | Cardiology | 515 | 86 | $10K |
| Jaime F Ruiz-Rodriguez San Juan, PR | Cardiology | 404 | 90 | $9,625 |
| Kevin K Kurohara Hilo, HI | Family Practice | 134 | 34 | $9,405 |
| Terry L Zellmer Baton Rouge, LA | Cardiology | 357 | 96 | $9,390 |
| George J Chilazi Taunton, MA | Cardiology | 327 | 110 | $9,129 |
| Russell E Dempsey Hudsonville, MI | Family Practice | 159 | 47 | $9,089 |
| Saul J Silver Pittsburgh, PA | Cardiology | 285 | 80 | $8,941 |
| Ildefonso Rivera Rivera Bayamon, PR | Cardiology | 206 | 72 | $8,822 |
| Mark Brown Phoenixville, PA | Internal Medicine | 342 | 83 | $8,819 |
| Jae U Hong Somerset, PA | Internal Medicine | 269 | 62 | $8,593 |
| Manuel A Quiles Lugo Santurce, PR | Cardiology | 287 | 61 | $8,421 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Unichem Pharmac UNICHEMLAB.NS | 213,915 | $5.7M |
| Edenbridge/Dexc | 159,291 | $4.7M |
| Mylan VTRS | 59,765 | $2.1M |
| Novitium/Ani Ph ANIP | 49,350 | $1.6M |
| Glenmark Pharma GLENMARK.NS | 29,454 | $900K |
| Teva USA TEVA | 29,371 | $812K |
| Viona Pharmaceu | 25,927 | $627K |
| Marlex Pharm. | 1,193 | $22K |